title: [Pharmacological and clinical profiles of the direct thrombin inhibitor dabigatran etexilate methane sulfate (Prazaxa(®)) ].
authors.affiliation: tsuyoshi.ohmura@boehringer-ingelheim.com
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Ohmura
authors.forename: Ikuma
authors.initials: I
authors.lastname: Takahashi
authors.forename: Kozaburo
authors.initials: K
authors.lastname: Ikegami
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Encinas
mesh_terms: D000818:Animals; D000991:Antithrombins / Q000494:pharmacology* / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000494:pharmacology* / Q000627:therapeutic use*; D000069604:Dabigatran; D000882:Haplorhini; D006801:Humans; D011725:Pyridines / Q000494:pharmacology* / Q000627:therapeutic use*; D051381:Rats; D020521:Stroke / Q000517:prevention & control; D013927:Thrombosis / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D011725:Pyridines; D014859:Warfarin; D000069604:Dabigatran